# Canary Medical Inc.

> Canary Medical builds sensor-equipped implants and the software that turns their signals into recovery benchmarks. Its commercial beachhead is the Canturio smart tibial extension inside Zimmer Biomet's Persona IQ knee, which passively records gait metrics and sends them to a clinician dashboard. The company sells through strategic device partners and supports reimbursable remote-monitoring workflows, positioning itself between orthopedic hardware, longitudinal health data, and enterprise clinical software.

- **Founded:** 2013
- **Headquarters:** Vancouver, Canada
- **Founders:** Bill Hunter (Founding Member, CEO and CMO), Fred Cushner (Founding Member and Chief Surgical Officer), Jeff Gross (Founding Member and CTO)
- **Team size:** Approximately 53-66 employees based on third-party company datasets
- **Products:** Canturio Tibial Extension with CHIRP, Canary Quantiles Recovery Curves, Canary Charm remote-monitoring platform, Canturio Smart Extension, Canturio Lumbar Cartridge
- **Notable:** Received FDA De Novo authorization in August 2021 for the first implantable post-surgical kinematic measurement knee-device category., Enabled Zimmer Biomet's commercially launched Persona IQ smart knee., Received four FDA Breakthrough Device designations across its pipeline by May 2024, according to the company.

## Products & services

- **Canturio Tibial Extension with CHIRP** — An implantable tibial stem extension containing motion sensors, a battery, memory, and wireless telemetry. In Zimmer Biomet's Persona IQ knee it reports step count, distance, cadence, walking speed, stride length, and range-of-motion metrics.
- **Canary Quantiles Recovery Curves** — Analytics that compare an individual patient's post-surgical gait against population cohorts by age, sex, and weeks since surgery.
- **Canary Charm remote-monitoring platform** — A clinician interface with sorting, filtering, patient dashboards, and support for RPM and RTM workflows and billing codes.
- **Canturio Smart Extension** — A shorter 30 mm smart tibial extension for smaller tibiae, cleared through the FDA 510(k) pathway as a line extension.
- **Canturio Lumbar Cartridge** — A smart-spine sensor cartridge intended to monitor fusion and possible instability after lumbar interbody procedures; it received FDA Breakthrough Device designation but public market authorization has not been established.
- **Cardiac Auscultation monitor** — An investigational implantable acoustic sensor for daily adjunctive monitoring of heart-failure physiology; a two-patient feasibility study was completed in Paraguay.

## Achievements

- Received FDA De Novo authorization in August 2021 for the first implantable post-surgical kinematic measurement knee-device category.
- Enabled Zimmer Biomet's commercially launched Persona IQ smart knee.
- Received four FDA Breakthrough Device designations across its pipeline by May 2024, according to the company.
- Completed a first-in-human, two-patient feasibility trial of an implantable cardiac auscultation sensor in 2024.
- Reported Persona IQ adoption at more than 300 hospitals and by more than 400 surgeons in 2025.
- A 2025 retrospective claims study associated smart implants with lower 90-day acute-care use and median post-operative costs, while noting observational limitations.
- Named Medical/Digital Technology Company of the Year in the 22nd annual LifeSciences BC Awards.

## Latest updates

- **2024-02** — Completed a two-patient first-in-human feasibility study of its investigational cardiac auscultation monitor in Paraguay.
- **2024-05** — Received FDA Breakthrough Device designation for the Canturio Lumbar Cartridge, Canary's first smart-spine application.
- **2025-05** — Initiated a Class II recall of 106 Canturio Smart Extension units distributed in Indiana because of incorrect labeling; the FDA attributed the cause to process change control.
- **2025-12** — Reported Persona IQ deployment across more than 300 hospitals and 400 surgeons, with 60% year-over-year growth.
- **2026-02** — A study of 7,861 smart-knee recipients compared step counts from the implant and Zimmer Biomet's smartphone-based care platform.
- **2026-05** — A published MedTech interview described Canary's strategy as embedding intelligence directly into medical devices and expanding the resulting data into clinical insight.

## Links

- Website: https://canarymedical.com
- LinkedIn: https://www.linkedin.com/company/canary-medical-inc.
- Twitter/X: https://twitter.com/canarymedical

---

Profile page: https://yespress.io/canary-medical-inc
Published by YesPress — https://yespress.io
Last updated: 2026-08-23